Core Viewpoint - The company expects a net loss of approximately HKD 21.8 million for the six months ending June 30, 2025, which is a significant increase from a net loss of about HKD 5.3 million in the same period of 2024 [1] Group 1: Financial Performance - The anticipated loss is primarily attributed to weak consumer market sentiment, slow economic recovery, and fragile consumer confidence [1] - The company's order volume has become conservative due to macroeconomic uncertainties and geopolitical tensions [1]

Group 1 - The company, Ebolu (01856), anticipates a net loss of approximately HKD 21.8 million for the six months ending June 30, 2025, which is a significant increase from a net loss of about HKD 5.3 million in the same period of 2024 [1] - The expected loss is primarily attributed to weak consumer market sentiment, slow economic recovery, and fragile consumer confidence [1] - The company has noted that macroeconomic uncertainties and geopolitical tensions have led to a more conservative order volume from clients [1]

Group 1 - The company expects to incur a net loss of approximately RMB 8 million to RMB 12 million in the first half of 2025, compared to a net loss of RMB 15.1 million in the first half of 2024 [1] - The anticipated loss is primarily attributed to intense competition in the local dental market, leading to increased customer acquisition costs and unstable conversion rates [1] - Economic recovery is slow, resulting in consumers preferring to save rather than spend on non-essential medical services, with patients opting for public hospitals or lower-cost private clinics [1] Group 2 - The company plans to increase advertising expenditures on online platforms and in-hospital promotional materials to enhance brand awareness and attract new customers [1] - Various sales strategies will be implemented to draw in new clientele amid the competitive landscape [1]